Focusing on a real world examples and a use case from BioReliance the three presentations from BioReliance, CIEA, and Taconic Biosciences in this 45-minute session highlighted the quality and the reliability of the rasH2 model as an alternative to the traditional two year bioassay.
Watch (or Download) the Presentations Now!
Ensuring rasH2 mouse model quality in an evolving carcinogenicity testing landscape (8 Minutes) Taconic BiosciencesThe quality control of rasH2 mice as a model for carcinogenicity study in regulatory purpose (15 Minutes) Koji Urano, Central Institute for Experimental Animals
Transgenic rasH2 mice for evaluation of carcinogenicity (20 Minutes) Marie McKeon, BioReliance
Watch the Presentations Now!
